Increasing Uptake of EHR-enabled Population Health Outreach Strategies to Improve Diabetes Screening
Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Feb 6, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The research team will conduct a pragmatic, split cluster randomized controlled trial (clinic=cluster; patient randomization) in 12 community-based primary care clinics in an integrated safety net health system serving a high-risk, racially/ethnically diverse population.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient is alive at time of data extraction
- • Age \>= 18 at time of data extraction and \<76
- • Visit with PCP at Parkland clinic in the last 18 months (548 days), where Encounter type = Virtual Visit or Encounter type = Office Visit
- • Patient NOT included in Parkland Diabetes Registry
- • Preferred language is Spanish or English
- • Ethnicity is Hispanic or Non-Hispanic
- • Race is White or Black
- • Patient is not pregnant in last 12 months
- • Exclusion Criteria for Study Population 1: Prediabetes Glycemic Risk Group
- • Last A1C value \<5.7 (normal)
- • Last A1C value \>6.4 (diabetes)
- • Last A1C value = blank (unchecked)
- • Last A1C date occurred within last 12 months from date of export
- • Exclusion Criteria for Study Population 2: Score-Based Glycemic Risk Group
- • Risk score \<9
- • Last A1C date occurred in last 30 months from date of export
- • Last A1C value was \>5.7 (PDM/DM)
About University Of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
Michael Bowen, MD
Principal Investigator
University of Texas Southwestern Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials